An international team of researchers has found that an antiviral drug -- interferon(IFN)-a2b -- can help speed up the recovery of COVID-19 patients.
Published in the journal Frontiers in Immunology, the study revealed that treatment with interferon(IFN)-a2b may significantly accelerate virus clearance and reduce levels of inflammatory proteins in COVID-19 patients.
"Rather than developing a virus-specific antiviral for each new virus outbreak, we should consider interferons as the 'first responders' in terms of treatment," said study lead researcher Dr Eleanor Fish professor in the University of Toronto, Canada.
The research team considered IFN-a therapy for COVID-19 after they demonstrated interferon provided therapeutic benefit during the SARS outbreak of 2002 and 2003.
They found that treatment with this drug, which has been used clinically for many years, significantly reduced the duration of detectable virus in the upper respiratory tract, on average by about seven days.
It also reduced blood levels of interleukin(IL)-6 and C-reactive protein (CRP), two inflammatory proteins found in COVID-19 patients.
For the findings, the researchers conducted this exploratory study on a group of 77 patients with COVID-19 in Wuhan, China.
They represented moderate cases of the disease as none of the patients required intensive care or prolonged oxygen supplementation or intubation.
According to the researchers, he work provides several important and novel insights into COVID-19 disease, notably that treatment with IFN-a2b can accelerate viral clearance from the upper respiratory tract and also reduce circulating levels of inflammatory factors that are associated with severe COVID-19.
Dr Fish said a randomised clinical trial is a crucial next step. According to her, a clinical trial with a larger group of infected patients who are randomised to treatment or placebo would further this research.
Another study, published in the journal The Lancet, stated that the two-week course of antiviral therapy that combines the power of three antiviral drugs has shown promise in treating hospitalised patients with mild to moderate COVID-19 virus.
The drug combination tested in the trial included -- interferon beta-1b which was developed to treat multiple sclerosis (MS), lopinavir-ritonavir which is normally used to treat HIV and ribavirin, an oral hepatitis C virus drug.
Air India Express strike: Air India to operate on AIX 20 routes
The Tata-owned Air India will operate 20 Air India Express (AIX) routes to help the latter amid an ongoing strike by cabin crew members, said an airline official on Thursday.
Tripura CM urges Railway Minister to resume train services hit by landslides in Assam
“The Chief Minister is personally monitoring the situation. He has asked the state officials to maintain close contact with the NFR engineers and officials to know the progress of the ongoing work,” an official said.
CCTV pictures of suspected terrorists behind Poonch attack surface
In the attack on the two-vehicle IAF convoy at Surankote tehsil in Poonch district, one air warrior named Corporal Vikky Pahade was killed, while four other IAF personnel were injured.
CMs of northeastern states slam Sam Pitroda's colour of citizens' remark, demand apology
Several Chief Ministers and leaders from the northeastern states condemned Congress leader Sam Pitroda's remark on the 'colour of citizens' and demanded his apology.
Students, faculties of BTVM observes Rabindra Jayanti
The Bhavan's Tripura Vidya Mandir on Wednesday observed Rabindra Jayanti in remembrance of world poet Rabindranath Tagore's birthday, where students and faculties of both the shifts participated.
Rajasthan resident held in state with cannabis worth Rs 1 lakh
A joint operation by the Government Railway Police (GRP) and Railway Protection Force (RPF) recovered 25 kg of ganja from Agartala railway station and arrested one person hailing from Rajasthan.
CM to campaign for BJP candidates in West Bengal on May 09
Chief Minister Prof. Dr. Manik Saha is set to actively participate in campaigning on May 09 for BJP candidates in the Lok Sabha elections in West Bengal, as confirmed by party sources today.
Congress wants to snatch reservation from backward classes and give it to Muslims: PM Modi
Prime Minister Narendra Modi on Wednesday alleged that the Congress wants to bring a legislation to snatch reservations for Scheduled Castes (SCs), Scheduled Tribes (STs), and Backward Classes (BCs) and give them to Muslims.